top of page

2022-10-19

Trazher 150 mg Powder for Concentrate for Solution for Infusion is approved in Singapore

Trazher 150 mg Powder for Concentrate for Solution for Infusion is approved in Singapore

On 19 Oct 2022, Trazher (Trastuzumab) Powder for Concentrate for Solution for Infusion 150mg/vial is approved by Health Sciences Authority (HSA) of Singapore. The Health Sciences Authority (HSA) is a statutory board under the Ministry of Health of the Government of Singapore. It is a multi-disciplinary agency, responsible for applying medical, pharmaceutical and scientific expertise to protect and advance public health and safety.

bottom of page